Advertisement
Review article| Volume 210, P182-188, March 2017

Download started.

Ok

Ischemia modified albumin in perinatology

Published:December 22, 2016DOI:https://doi.org/10.1016/j.ejogrb.2016.12.022

      Abstract

      Ischemia modified albumin is a novel marker of ischemia generated due to hypooxygenation and increased hydroxyl free radicals in low pH. The molecule has been licenced for clinical use as an early marker for acute coronary syndrome in cardiology. Since presence of ischemia might have serious and sometimes devastating effects in perinatology, various researches have evaluated its value in different clinical conditions. This narrative review aims to summarize the literature concerning the value of IMA in perinatology and guide for further research.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      References

        • Gaze D.C.
        • Crompton L.
        • Collinson P.
        Ischemia-modified albumin concentrations should be interpreted with caution in patients with low serum albumin concentrations.
        Med Princ Pract. 2006; 15: 322-324
        • Dominguez-Rodriguez A.
        • Abreu-Gonzalez P.
        Current role of ischemia-modified albumin in routine clinical practice.
        Biomarkers. 2010; 15: 655-662
        • Lippi G.
        • Montagnana M.
        • Guidi G.C.
        Albumin cobalt binding and ischemia modified albumin generation: an endogenous response to ischemia?.
        Int J Cardiol. 2006; 108: 410-411
        • Turedi S.
        • Gunduz A.
        • Mentese A.
        • Karahan S.C.
        • Yilmaz S.E.
        • Eroglu O.
        • et al.
        Value of ischemia-modified albumin in the diagnosis of pulmonary embolism.
        Am J Emerg Med. 2007; 25: 770-773
        • Piwowar A.
        • Knapik-Kordecka M.
        • Warwas M.
        Ischemia-modified albumin level in type 2 diabetes mellitus–preliminary report.
        Dis Markers. 2008; 24: 311-317
        • Can M.
        • Demirtas S.
        • Polat O.
        • Yıldız A.
        The evaluation of the ischemic effects on albumin cobalt binding assay (ACB) in the patients who exposured to trauma.
        Emerg Med J. 2006; 23 (2006): 537-539
        • Çavuşoğlu Y.
        • Korkmaz Ş.
        • Demirtaş S.
        • Gencer E.
        • Şaşmaz H.
        • Mutlu F.
        • et al.
        Ischemia-modified albumin levels in patients with acute decompensated heart failure treated with dobutamine or levosimendan: IMA-HF study.
        Anatol J Cardiol. 2015; 15: 611-617
        • Şeker R.
        • Oğuz A.K.
        • Özdemir S.
        • Demirtaş S.
        • Aylı M.
        • Mergen K.
        The evaluation of IMA as a cardiac ischemia marker in the cases of hypohemoglobinemia and hypoxemia due to blood loss.
        Turk Biochem. 2014; 39: 221-225
        • Roy D.
        • Quiles J.
        • Sharma R.
        • Sinha M.
        • Avanzas P.
        • Gaze D.
        • et al.
        Ischemia-modified albumin concentrations in patients with peripheral vascular disease and exercise-induced skeletal muscle ischemia.
        ClinChem. 2004; 50: 1656-1660
        • Zapico-Muñiz E.
        • Santaló-Bel M.
        • Mercé-Muntañola J.
        • Montiel J.A.
        • Martínez-Rubio A.
        • Ordóñez-Llanos J.
        Ischemia-modified albumin during skeletal muscle ischemia.
        Clin Chem. 2004; 50 (2004): 1063-1065
        • Hakligör A.
        • Kösem A.
        • Seneş M.
        • Yücel D.
        Effect of albumin concentration and serum matrix on ischemia-modified albumin.
        Clin Biochem. 2010; 43: 345-348
        • Gidenne S.
        • Ceppa F.
        • Fontan E.
        • Perrier F.
        • Burnat P.
        Analytical performance of the albumin cobalt binding (ACB) test on the cobas MIRA plus analyzer.
        Clin Chem Lab Med. 2004; 42: 455-461
        • Bar-Or D.
        • Lau E.
        • Winkler J.V.
        Novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia–a preliminary report.
        J Emerg Med. 2000; 19: 311-315
        • Fagan G.J.
        • Wayment H.
        • Morris D.L.
        • Crosby P.A.
        The albumin cobalt binding test: analytical performance of a new automated chemistry assay for the detection of ischemia modified albumin (IMA).
        J Clin Ligand Assay. 2002; 25: 178-187
        • Cengiz H.
        • Dagdeviren H.
        • Kanawati A.
        • Çaypinar S. Suzen
        • Yesil A.
        • Ekin M.
        • et al.
        Ischemia-modified albumin as an oxidative stress biomarker in early pregnancy loss.
        J Maternal Fetal Neonatal Med. 2015; 18: 1-4
        • Gidenne S.
        • Ceppa F.
        • Fontan E.
        • Perrier F.
        • Burnat P.
        Analytical performance of the albumin cobalt binding (ACB) test on the cobas MIRA plus analyzer.
        Clin Chem Lab Med. 2004; 42: 455-461
        • Soldin S.J.
        • Brugnara C.
        • Hicks J.M.
        Pediatric reference ranges.
        3rd ed. AACC Press, Washington, DC1999
      1. http://perinatology.com/Reference/Reference%20Ranges/Albumin.htm.

        • Lee Y.W.
        • Kim H.J.
        • Cho Y.H.
        • Shin H.B.
        • Choi T.Y.
        • Lee Y.K.
        Application of albumin-adjusted ischemia modified albumin index as an early screening marker for acute coronary syndrome.
        Clin Chim Acta. 2007; 384 (18): 24-27
        • Lippi G.
        • Montagnana M.
        • Salvagno G.L.
        • Guidi G.C.
        Standardization of ischemia-modified albumin testing: adjustment for serum albumin.
        Clin Chem Lab Med. 2007; 45: 261-262
        • D'souza J.M.
        • Pai V.R.
        • Harish S.
        • Shriyan C.
        • D'souza N.
        IMA and IMAR in serum and saliva of preeclampsia–a preliminary study.
        Hypertens Pregnancy. 2014; 33: 440-448
        • Prefumo F.
        • Gaze D.C.
        • Papageorghiou A.T.
        • Collinson P.O.
        • Thilaganathan B.
        First trimester maternal serum ischaemia-modified albumin: a marker of hypoxia-ischaemia-driven early trophoblast development.
        Hum Reprod. 2007; 22: 2029-2032
        • Jauniaux E.
        • Hempstock J.
        • Greenwold N.
        • et al.
        Trophoblastic oxidative stress in relation to temporal and regional differences in maternal placental blood flow in normal and abnormal early pregnancies.
        Am J Pathol. 2003; 162: 115-125
        • Jauniaux E.
        • Gulbis B.
        • Burton G.J.
        The human first trimester gestational sac limits rather than facilitates oxygen transfer to the foetus—a review.
        Placenta. 2003; 24: S86-93
        • Guven S.
        • Alver A.
        • Mentese A.
        • Ilhan F.C.
        • Calapoglu M.
        • Unsal M.A.
        The novel ischemia marker ‘ischemia-modified albumin' is increased in normal pregnancies.
        Acta Obstet Gynecol Scand. 2009; 88: 479-482
        • Özdemir S.
        • Kıyıcı A.
        • Balci O.
        • Göktepe H.
        • Çiçekler H.
        • Çelik Ç.
        Assessment of ischemia-modified albumin level in patients with recurrent pregnancy loss during the firsttrimester.
        Eur J Obstet Gynecol Reprod Biol. 2011; 155: 209-212
        • Hustin J.
        • Jauniaux E.
        • Schaaps J.P.
        Histological study of the materno-embryonic interface in spontaneous abortion.
        Placenta. 1990; 11: 477-486
        • Hjortshoj S.
        • Kristensen S.R.
        • Ravkilde J.
        Diagnostic value of ischemiamodified albumin in patients with suspected acute coronary syndrome.
        Am J Emerg Med. 2010; 28: 170-176
        • Ma S.G.
        • Xu W.
        • Wei C.L.
        • Wu X.J.
        • Hong B.
        • Wang Z.J.
        • et al.
        Role of ischemia-modified albumin and total homocysteine in estimating symptomatic lacunar infarction in type 2 diabetic patients.
        Clin Biochem. 2011; 44: 1299-1303
        • Ma S.G.
        • Yu W.N.
        • Jin Y.
        • Hong B.
        • Hu W.
        Evaluation of serum ischemia-modified albumin levels in pregnant women with and without gestational diabetesmellitus.
        Gynecol Endocrinol. 2012; 28: 837-840
        • Dahiya K.
        • Kulshrestha M.R.
        • Bansal P.
        • Ghalaut V.S.
        • Kulshrestha R.
        • Dahiya P.
        • et al.
        Evaluation of cord blood ischemia modified albumin in normal pregnancies and pre-eclampsia.
        Hypertens Pregnancy. 2015; 34: 204-208
        • Jia Z.T.
        • Liu C.Y.
        • Li H.
        Changes of the concentration of serum ischemia modified albumin and high sensitivity C-reactive protein in type 2 diabetic patients with retinopathy.
        Zhonghua Yan Ke Za Zhi. 2009; 45: 805-808
        • Makedou K.
        • Kourtis A.
        • Gkiomisi A.
        • Toulis K.A.
        • Mouzaki M.
        • Anastasilakis A.D.
        • et al.
        Oxidized low-density lipoprotein and adiponectin levels in pregnancy.
        Gynecol Endocrinol. 2011; 27: 1070-1073
        • Rossi A.
        • Bortolotti N.
        • Vescovo S.
        • Romanello I.
        • Forzano L.
        • Londero A.P.
        • et al.
        Ischemia-modified albumin in pregnancy.
        Eur J Obstet Gynecol Reprod Biol. 2013; 170: 348-351
        • van Rijn B.B.
        • Franx A.
        • Sikkema J.M.
        • van Rijn H.J.
        • Bruinse H.W.
        • Voorbij H.A.
        Ischemia modified albumin in normal pregnancy and preeclampsia.
        Hypertens Pregnancy. 2008; 27: 159-167
        • Kliman H.J.
        Uteroplacental blood flow The story of decidualization, menstruation, and trophoblast invasion.
        Am J Pathol. 2000; 157: 1759-1768
        • Brosens J.J.
        • Pijnenborg R.
        • Brosens I.A.
        The myometrial junctional zone spiral arteries in normal and abnormal pregnancies: a review of the literature.
        Am J Obstet Gynecol. 2002; 187: 1416-1423
        • Gafsou B.
        • Lefèvre G.
        • Hennache B.
        • Debarge V. Houfflin
        • Ducloy-Bouthors A.S.
        Maternal serum ischemiamodified albumin: biomarker to distinguish between normal pregnancy andpreeclampsia?.
        Hypertens Pregnancy. 2010; 29: 101-111
        • Ustun Y.
        • Engin-Ustun Y.
        • Ozturk O.
        • Alanbay I.
        • Yaman H.
        Ischemia-modified albumin as an oxidative stress marker in preeclampsia.
        J Maternal Fetal Neonatal Med. 2011; 24: 418-421
        • Papageorghiou A.T.
        • Prefumo F.
        • Leslie K.
        • Gaze D.C.
        • Collinson P.O.
        • Thilaganathan B.
        Defective endovascular trophoblast invasion inthe first trimester is associated with increased maternal maternal serumischemia-modified albumin.
        Hum Reprod. 2008; 23: 803-806
        • Omür D.
        • Hacivelioglu S.Ö.
        • Oguzalp H.
        • Uyan B.
        • Kiraz H.A.
        • Duman C.
        • et al.
        The effect of anaesthesia technique on maternal and cord blood ischaemiamodified albumin levels duringcaesarean section: a randomized controlled study.
        J Int Med Res. 2013; 41: 1111-1119
        • Caglar G.S.
        • Erdogdu P.
        • Gursoy A.Y.
        • Seker R.
        • Demirtaş S.
        The impact of route of anesthesia on maternal and fetal ischemia modified albümin levels at cesarean section: a prospective randomized study.
        J Perinat Med. 2013; 41: 573-579
        • Iacovidou N.
        • Briana D.D.
        • Boutsikou M.
        • Liosi S.
        • Baka S.
        • Boutsikou T.
        • et al.
        Cord blood ischemia-modified albumin levels in normal and intrauterine growth restricted pregnancies.
        Mediators Inflamm. 2008; 2008: 523081https://doi.org/10.1155/2008/523081
        • Caglar G.S.
        • Tasci Y.
        • Goktolga U.
        • Oztas E.
        • Pabuccu R.
        • Ozdemir E.D.
        • et al.
        Maternal and umbilical cord ischemia-modified albumin levels in nonreassuring fetal heart rate tracings regarding the mode of delivery.
        J Maternal Fetal Neonatal Med. 2013; 26: 528-531
        • Topaloğlu N.
        • Yıldırım Ş.
        • Tekin M.
        • Kaymaz N.
        • Tütüncüler F.
        • Özdemir C.
        • et al.
        Mean platelet volume and ischemia modified albumin levels in cord blood of infants of diabetic mothers.
        Pediatr Neonatol. 2014; 55: 455-458
        • Toy H.
        • Camuzcuoglu H.
        • Arioz D.T.
        • Kurt S.
        • Celik H.
        • Aksoy N.
        Serum prolidase activity and oxidative stress markers in pregnancies with intrauterine growth restricted infants.
        J Obstet Gynaecol Res. 2009; 35: 1047-1053
        • Guvendag Guven E.S.
        • Karcaaltincaba D.
        • Kandemir O.
        • Kiykac S.
        • Mentese A.
        Cord blood oxidative stress markers correlate with umbilical artery pulsatility in fetal growth restriction.
        J Maternal Fetal Neonatal Med. 2013; 26: 576-580
        • Mehmetoglu I.
        • Kurban S.
        • Toker A.
        • Annagür A.
        • Altunhan H.
        • Erbay E.
        • et al.
        Serum ischemia-modified albumin and oxidized LDL in cord blood and serum of neonates born to pre-eclamptic mothers.
        Pediatr Int. 2015; 57: 422-426
        • Gugliucci A.
        • Hermo R.
        • Monroy C.
        • Numaguchi M.
        • Kimura S.
        Ischemia-modified albumin levels in cord blood: a case-control study in uncomplicated and complicated deliveries.
        Clin Chim Acta. 2005; 362: 155-160
        • Dursun A.
        • Okumus N.
        • Zenciroglu A.
        Ischemia-modified albumin (IMA): could it be useful to predict perinatal asphyxia?.
        J Maternal Fetal Neonatal Med. 2012; 25: 2401-2405
        • Kumral A.
        • Okyay E.
        • Guclu S.
        • Gencpinar P.
        • Islekel G.H.
        • Oguz S.S.
        • et al.
        Cord blood ischemia-modified albumin:is it associated with abnormal Doppler findings in complicatedpregnancies and predictive of perinatal asphyxia?.
        J Obstet Gynaecol Res. 2013; 39: 663-671
        • Oztekın O.
        • Kalay S.
        • Tayman C.
        • Namuslu M.
        • Celık H.T.
        Levels of ischemia-modified albumin in transient tachypnea of the newborn.
        Am J Perinatol. 2015; 30: 193-198
        • Yakut I.
        • Tayman C.
        • Oztekin O.
        • Namuslu M.
        • Karaca F.
        • Kosus A.
        Ischemia-modified albumin may be a novel marker for the diagnosis and follow-up of necrotizing enterocolitis.
        J Clin Lab Anal. 2014; 28: 170-177
        • Yerlikaya F.H.
        • Kurban S.
        • Mehmetoglu I.
        • Annagur A.
        • Altunhan H.
        • Erbay E.
        • et al.
        Serum ischemia-modified albumin levels at diagnosis and during treatment of late-onset neonatal sepsis.
        J Matern Fetal Neonatal Med. 2014; 27: 1723-1727